当前位置: 首页 >> 检索结果
共有 7649 条符合本次的查询结果, 用时 4.5442809 秒

6861. With the Merit-Based Incentive Payment System, Pay for Performance Is Now National Policy.

作者: Teryl K Nuckols.
来源: Ann Intern Med. 2017年166卷5期368-369页

6862. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.

作者: Karsten Juhl Jørgensen.;Peter C Gøtzsche.;Mette Kalager.;Per-Henrik Zahl.
来源: Ann Intern Med. 2017年166卷5期313-323页
Effective breast cancer screening should detect early-stage cancer and prevent advanced disease.

6863. Breast Cancer: Tumor Size and Overdiagnosis.

来源: Ann Intern Med. 2017年166卷5期

6864. Patient, Provider, and Combined Interventions for Managing Osteoarthritis in Primary Care: A Cluster Randomized Trial.

作者: Kelli D Allen.;Eugene Z Oddone.;Cynthia J Coffman.;Amy S Jeffreys.;Hayden B Bosworth.;Ranee Chatterjee.;Jennifer McDuffie.;Jennifer L Strauss.;William S Yancy.;Santanu K Datta.;Leonor Corsino.;Rowena J Dolor.
来源: Ann Intern Med. 2017年166卷6期401-411页
A single-site study showed that a combined patient and provider intervention improved outcomes for patients with knee osteoarthritis, but it did not assess separate effects of the interventions.

6865. Accepting the Existence of Breast Cancer Overdiagnosis.

作者: Otis W Brawley.
来源: Ann Intern Med. 2017年166卷5期364-365页

6866. Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets.

来源: Ann Intern Med. 2017年166卷6期

6867. The Effects of Pay-for-Performance Programs on Health, Health Care Use, and Processes of Care: A Systematic Review.

作者: Aaron Mendelson.;Karli Kondo.;Cheryl Damberg.;Allison Low.;Makalapua Motúapuaka.;Michele Freeman.;Maya O'Neil.;Rose Relevo.;Devan Kansagara.
来源: Ann Intern Med. 2017年166卷5期341-353页
The benefits of pay-for-performance (P4P) programs are uncertain.

6868. Blood Pressure Treatment Targets in Adults Aged 60 Years or Older.

作者: Michael Pignone.;Anthony J Viera.
来源: Ann Intern Med. 2017年166卷6期445-446页

6869. Web Exclusives. Annals Consult Guys - Measuring Lipids: To Fast or Not to Fast.

作者: Geno J Merli.;Howard H Weitz.
来源: Ann Intern Med. 2017年166卷2期CG1页

6870. Web Exclusives. Annals for Hospitalists Inpatient Notes - Rituals in Chaos, the Sacred in the Profane.

作者: Poonam Hosamani.;Abraham Verghese.
来源: Ann Intern Med. 2017年166卷2期HO2页

6871. Historical Perspective on the Rise and Fall and Rise of Antibiotics and Human Weight Gain.

作者: Scott H Podolsky.
来源: Ann Intern Med. 2017年166卷2期133-138页
In recent medical and popular literature, audiences have been asked to consider whether antibiotics have contributed to the rising obesity epidemic. Prominent magazines have stated that weight may be adversely affected by antibiotics that destroy existing microbiomes and replace them with less helpful ones. However, there is a long history of efforts to investigate the relationship between antibiotics and human weight gain. In the early 1950s, amid initial findings that low doses of antibiotics served as growth promoters in animal livestock, investigators explored the role of antibiotics as magic bullets for human malnutrition. Nevertheless, early enthusiasm was tempered by controlled studies showing that antibiotics did not serve as useful, nonspecific growth promoters for humans. In subsequent decades, against the backdrop of rising concern over antibiotic resistance, investigators studying the role of antibiotics in acute malnutrition have had to navigate a more complicated public health calculus. In a related historical stream, scientists since the 1910s have explored the role of the intestinal microflora in human health. By the 2000s, as increasing resources and more sophisticated tools were devoted to understanding the microbiome (a term coined in 2001), attention would turn to the role of antibiotics and the intestinal microflora in the rising obesity epidemic. Despite scientific and commercial enthusiasm, easy answers (whether about antibiotics or probiotics) have again given way to an appreciation for the complexity of human growth. History encourages caution about our hopes for simplistic answers for presumed "fat drugs" and slimming probiotics alike.

6872. Blanket Signs.

作者: Iris Ma.
来源: Ann Intern Med. 2017年166卷2期150-151页

6873. Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect.

作者: William D Leslie.;Sumit R Majumdar.;Suzanne N Morin.;Lisa M Lix.
来源: Ann Intern Med. 2017年166卷2期152-153页

6874. Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect.

作者: Katy J L Bell.;Andrew Hayen.;Paul Glasziou.;Les Irwig.;Douglas C Bauer.
来源: Ann Intern Med. 2017年166卷2期152页

6875. Hypervitaminosis D Associated With Tanning Bed Use: A Case Report.

作者: Michaël R Laurent.;Evelien Gielen.;Steven Pauwels.;Dirk Vanderschueren.;Roger Bouillon.
来源: Ann Intern Med. 2017年166卷2期155-156页

6876. IgG4-Related Disease in Monozygotic Twins: A Case Report.

作者: Aurélie Grados.;Thibaud Vaysse.;Mikael Ebbo.;Franck Carbonnel.;Nicolas Schleinitz.
来源: Ann Intern Med. 2017年166卷2期153-155页

6877. In older adults with COPD, new opioid use was linked to increased risk for respiratory and all-cause mortality.

作者: Mitchell Levine.
来源: Ann Intern Med. 2017年166卷2期JC11页

6878. In patients with severe sepsis, hydrocortisone did not prevent progression to septic shock.

作者: Bram Rochwerg.;Gordon Guyatt.
来源: Ann Intern Med. 2017年166卷2期JC10页

6879. Review: Some drugs, added to hydration, prevent contrast-induced acute kidney injury.

作者: Catherine M Clase.
来源: Ann Intern Med. 2017年166卷2期JC9页

6880. Semaglutide reduced a composite of CV events at 2 years in patients with type 2 diabetes and high CV risk.

作者: Anthony A Donato.
来源: Ann Intern Med. 2017年166卷2期JC8页
共有 7649 条符合本次的查询结果, 用时 4.5442809 秒